well
cytokin
import
immun
reaction
inflamm
data
indic
patient
sever
exhibit
overal
declin
lymphocyt
includ
cell
b
cell
nk
cell
number
immunosuppress
regulatori
cell
moder
increas
patient
mild
remark
upregul
patient
sever
level
rel
length
hospit
stay
underw
similar
risedeclin
pattern
probabl
reflect
therapeut
effect
conclus
studi
show
comprehens
decreas
lymphocyt
elev
reliabl
indic
sever
coronaviru
diseas
respiratori
disord
caus
new
coronaviru
term
viru
probabl
aros
unidentifi
anim
sourc
subsequ
transmit
person
person
transmiss
air
cough
sneez
close
person
contact
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
touch
viruscontamin
object
touch
mouth
nose
possibl
eye
initi
manifest
includ
cough
fever
respiratori
distress
thorough
clinic
profil
complet
comprehend
report
ill
rang
mild
sever
even
death
sever
vari
among
individu
patient
outbreak
among
patient
group
differ
outbreak
differ
region
immun
respons
patient
either
system
local
well
studi
even
one
month
outbreak
china
although
chest
ct
scan
suggest
progress
pneumonia
patient
inflammatori
process
immun
reaction
detail
one
report
elev
neutrophil
cellular
serum
creactiv
protein
found
togeth
lymphopenia
patient
clinic
studi
indic
patient
develop
lymphopenia
highlevel
variou
cytokin
gcsf
surg
proinflammatori
cytokin
incur
cytokin
storm
might
induc
viral
sepsi
tissueorgan
damag
result
shock
even
multipl
organ
failur
antibodi
seem
produc
patient
suggest
mount
humor
respons
howev
comprehens
statu
either
innat
immun
adapt
immun
patient
remain
larg
unknown
current
studi
analyz
multipl
cytokin
immun
cell
popul
blood
chines
patient
studi
outlin
immunopatholog
profil
patient
may
provid
help
inform
develop
futur
therapi
infect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
two
four
millilit
peripher
venou
blood
withdrawn
patient
edta
blood
collect
tube
complet
blood
cell
count
perform
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
automat
blood
analyz
sysmex
reagent
calibr
qualiti
control
vendor
analyz
serum
cytokin
whole
blood
centrifug
minut
c
serum
care
harvest
store
c
analysi
multipl
serum
cytokin
quantifi
use
human
cytokin
kit
ii
guangzhou
weimi
biotech
follow
manufactur
manual
measur
lymphocyt
cell
subset
whole
blood
incub
trisnh
cl
buffer
thermo
fisher
scientif
room
temperatur
minut
lyse
erythrocyt
two
wash
phosphatebuff
salin
pb
cell
incub
bd
multitest
tbnk
reagent
bd
multitest
bd
bioscienc
follow
vendor
instruct
anoth
two
wash
pb
cell
resuspend
pb
evalu
regulatori
cell
erythrocyt
lyse
describ
blood
sampl
incub
fitcconjug
antibodi
violet
antibodi
percpconjug
antibodi
apcconjug
antibodi
bd
bioscienc
minut
ice
anoth
two
wash
pb
cell
resuspend
pb
sampl
analyz
bd
facscanto
plu
flow
cytomet
among
collect
event
singl
event
gate
fsca
fsch
cell
debri
exclud
intact
cell
gate
singl
event
base
fsca
ssc
cell
popul
detect
base
antibodi
stain
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
data
indic
mean
standard
deviat
measur
graphpad
prism
non
parametr
kruskalw
test
oneway
anova
posthoc
tukey
hsd
test
appli
compar
mean
valu
mean
rank
among
differ
group
depend
presenc
absenc
gaussian
distribut
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
assess
gener
immun
statu
patient
first
quantifi
absolut
number
whole
white
blood
cell
wbc
immun
cell
popul
blood
sampl
patient
inpati
admiss
indic
figur
wbc
number
significantli
decreas
mild
patient
compar
control
group
howev
wbc
number
remark
chang
sever
patient
total
lymphocyt
number
decreas
sever
patient
mild
patient
suggest
lymphopenia
sever
patient
figur
neutrophil
increas
sever
patient
mild
patient
figur
neutrophiltolymphocyt
ratio
nlr
consist
chang
lymphocyt
moder
increas
mild
patient
profoundli
increas
sever
patient
comparison
control
group
figur
analyz
adapt
immun
cell
popul
conduct
flow
cytometri
analysi
total
cell
helper
cell
cytotox
cell
figur
found
similar
decreas
lymphocyt
patient
figur
total
cell
number
significantli
decreas
patient
signific
differ
observ
mild
sever
patient
figur
similarli
helper
cell
cytotox
cell
diminish
patient
compar
control
group
signific
differ
found
mild
sever
patient
figur
ratio
cell
cell
chang
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
immun
cell
includ
b
cell
nk
cell
nkt
cell
also
evalu
blood
sampl
figur
found
comparison
control
group
trend
decreas
b
cell
cellular
mild
patient
notabl
reduct
b
cell
sever
patient
figur
similar
decreas
also
seen
patient
nk
cell
figur
remark
chang
nkt
cellular
observ
patient
figur
treg
import
cell
subset
immun
toler
antiinflammatori
reaction
studi
measur
cellular
cell
consid
tregenrich
popul
figur
found
treg
increas
mild
patient
compar
control
figur
slight
increas
treg
sever
patient
figur
figur
demonstr
figur
compar
control
consider
increas
sever
patient
mild
patient
remark
rais
mild
patient
sever
patient
figur
significantli
increas
sever
patient
mild
patient
figur
like
significantli
increas
sever
patient
mild
patient
figur
howev
show
signific
chang
patient
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
also
evalu
cytokin
concentr
rel
length
stay
hospit
found
sever
patient
alway
higher
level
mild
patient
time
interv
reach
peak
sever
patient
day
follow
moder
declin
significantli
chang
mild
patient
along
stay
figur
dramat
tempor
chang
observ
either
mild
patient
sever
patient
figur
level
mild
patient
alway
low
drastic
increas
sever
patient
interestingli
stay
rel
stabl
level
within
two
week
went
day
follow
declin
back
initi
level
figur
alway
higher
sever
patient
mild
patient
besid
sever
patient
underw
upregul
day
day
respect
figur
chang
level
almost
neglect
figur
suggest
probabl
good
indic
sever
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
outbreak
pose
urgent
demand
understand
role
immun
progress
viral
infect
subsequ
pneumonia
new
coronaviru
highli
contagi
probabl
owe
viru
spread
asymptomaticinfect
individu
recent
public
character
comprehens
chang
innat
adapt
immun
infect
peopl
although
nonpeer
review
sourc
medrxiv
releas
inform
present
clinic
studi
analyz
almost
immun
cell
type
mild
sever
patient
found
lymphopenia
consist
former
report
neutrophil
howev
increas
sever
patient
noteworthi
lymphopenia
seem
aris
comprehens
reduct
lymphocyt
popul
includ
cell
b
cell
nk
cell
decreas
blood
lymphocyt
might
due
recruit
reactiv
lymphocyt
lung
help
investig
infiltr
cell
lung
test
infiltr
predominantli
lymphocyt
granulocyt
anoth
possibl
lymphocyt
sensit
granulocyt
disturb
homeostasi
underw
signific
cell
death
whatev
case
lymphopenia
indic
sever
patient
phenomenon
might
suggest
recruit
reactiv
antivir
cell
infect
site
accord
report
cell
respons
sarscov
infect
cell
reaction
frequent
robust
cell
reaction
therefor
possibl
also
case
inde
latest
case
report
show
sign
excess
cell
activ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
evidenc
high
proport
hladr
doubleposit
cell
fraction
unpublish
data
indic
highli
expand
clonal
cell
lung
microenviron
mild
patient
suggest
robust
adapt
immun
respons
connect
better
control
http
howev
b
cell
nk
cell
number
also
remark
reduc
sever
patient
suggest
profound
suppress
lymphocyt
interestingli
treg
play
crucial
role
immunoregul
antiinflammatori
respons
elev
mild
patient
suggest
possibl
immunosuppress
sever
patient
treg
cellular
compar
control
individu
probabl
due
overal
cell
defici
although
reduct
lymphocyt
clear
chang
function
lymphocyt
popul
remain
unknown
futur
necessari
test
function
distinct
immun
cell
popul
tell
whether
innat
adapt
immun
activ
impair
recent
research
reveal
fatal
cytokin
storm
critic
patient
increas
serum
observ
patient
sever
cytokin
level
also
evalu
studi
found
serum
mainli
upregul
sever
patient
first
three
cytokin
exhibit
meaning
increas
thu
serum
could
use
assess
sever
cytokin
produc
innat
immun
cell
adapt
immun
cell
mainli
secret
activ
cell
higher
level
patient
like
reflect
cell
activ
wellknown
proinflammatori
cytokin
also
act
antiinflammatori
mediat
cellular
sourc
includ
myeloid
cell
cell
smooth
muscl
cell
endotheli
cell
etc
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
dramat
increas
like
origin
activ
macrophag
consist
anoth
report
similar
upregul
sar
patient
act
antiinflammatori
cytokin
deriv
altern
activ
macrophag
cell
treg
etc
conclus
studi
show
comprehens
decreas
lymphocyt
elev
reliabl
indic
sever
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
